Stock listing
UPB Stock Price, News, Filings & Events — Upstream Bio, Inc.
Selected listing: UPB · NASDAQ · USD · US
This page tracks Upstream Bio, Inc.'s UPB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UPB:NASDAQ. UPB:NASDAQ is the stock-level entry point for investors researching Upstream Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Upstream Bio, Inc. is a public company traded under the ticker UPB in the American market. With a market capitalization of approximately $348.8 million, the company is focused on advancing its biotechnology initiatives. Investors can find detailed information about its operations and performance on its public company page.

- Ticker
- UPB:NASDAQ
- Asset type
- Stock
- Market cap
- $313.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Upstream Bio, Inc. UPB:NASDAQ stock context
This page tracks Upstream Bio, Inc.'s UPB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UPB:NASDAQ. UPB:NASDAQ is the stock-level entry point for investors researching Upstream Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Upstream Bio, Inc. is a public company traded under the ticker UPB in the American market. With a market capitalization of approximately $348.8 million, the company is focused on advancing its biotechnology initiatives. Investors can find detailed information about its operations and performance on its public company page.
Latest news from Upstream Bio, Inc.
Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress
August 11, 2026
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Partic...
June 14, 2026
Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026
June 8, 2026
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 3, 2026
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participant...
May 18, 2026
Research Upstream Bio, Inc.
Upstream Bio, Inc. investor report
Review AI stock analysis and investor report context for UPB:NASDAQ.
Upstream Bio, Inc. company profile
View the public company page for Upstream Bio, Inc. on 6ix.
Upstream Bio, Inc. news
Read company news and market updates connected to Upstream Bio, Inc..
Upstream Bio, Inc. investor events
Find investor webinars, events, and replay context for Upstream Bio, Inc..